European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Tenders

Oncology drug tenders in Italy

Oncology drug tenders in Italy: 1,710 listed on GranTender since 2024. The median awarded contract value is about €39,000 (1,627 contracts with a stated value). Buyers with the most tenders: Azienda Sanitaria Provinciale (465), Sanitaetsbetrieb der Autonomen Provinz Bozen (221) and Azienda Ulss N. 1 Dolomiti (97); suppliers with the most contract awards: PFIZER S.R.L. (72), Novartis Farma SPA (56) and Janssen Cilag S.P.A. (48). Sources: ANAC, ANAC Pubblicità Legale and TED. In 2025 the median contract value was €39,000. Data as of 18 November 2026; updated daily.

Tenders
1,710
Open tenders
0
Awards
1,645
Awarded value awarded
€467,379,040
Awarded value framework ceiling
€3,715,501
Median contract value awarded
≈ €39,000
Tenders in 2025
732 +48% on 2024

Median: contracts with a stated value, rounded. Average bids: contracts where the number of bids is published.

Value kinds: awarded — the value in the award decision; contract — the value of the signed or amended contract; paid — the amount actually paid; framework ceiling — the maximum of a framework agreement, given with every winner, not money spent. Different kinds are never added together.

Open tenders

No records yet.

Latest tenders

TenderBuyerEstimated valueStatusPublished
PROCEDURA NEGOZIATA SENZA PUBBLICAZIONE DI UN BANDO, AI SENSI DELL'ART. 76, COMMA 2 LETT. B) N. 2 DEL D. LGS. 36/2023 PER L'AFFIDAMENTO DELLA FORNITURA DI SACCHE MULTIDOSE E MULTIPRELIEVO DI FARMACI CHEMIOTERAPICI E SERVIZI ACCESSORI OCCORRENTE ALL'ASST NORD MILANO PER UN PERIODO DI 60 MESI.Azienda Socio-Sanitaria Territoriale Nord Milano€2,222,250Awarded13 October 2026
SERVIZIO di VALUTAZIONE DELLA CONTAMINAZIONE AMBIENTALE DA CHEMIOTERAPICI SU SUPERFICI E SU DPI INDOSSATI DAGLI OPERATORI (WIPE TEST E PAD TEST) con particolare attenzione alle fluoropirimidine, alla ciclofosfamide e alla gemcitabina.IRCCS Ospedale Policlinico San Martino—Awarded8 October 2026
Affidamento diretto di un di un servizio di controlli microbiologici delle superfici e dell’aria nelle sale operatorie - neonatologia e dei controlli microbiologici e chimici alla ricerca di farmaci antiblastici più tossici – UFA – Polo Ospedaliero ASL Roma 4 per la durata di 24 mesi.Azienda Usl RMF—Awarded7 October 2026
PROCEDURA DI AFFIDAMENTO DEI SERVIZI DI MANUTENZIONE CORRETTIVA RELATIVI AL SOFTWARE DI GESTIONE DEI FARMACI ANTIBLASTICIASL Napoli 2 Nord—Awarded2 October 2026
FORNITURA DEL FARMACO CARVYKTIAzienda Unita Locale Socio-Sanitaria N. 8 Berica€2,604,000Closed2 October 2026
FORNITURA DEL FARMACO ORSERDUSanitaetsbetrieb der Autonomen Provinz Bozen€139,924Awarded28 September 2026
AFFIDAMENTO DIRETTO PER LAVORI DI MANUTENZIONE STRAORDINARIA PER ADEGUAMENTO IMPIANTO TRATTAMENTO ARIA DEI LABORATORI GALENICI E ANTIBLASTICI.Azienda Socio Sanitaria Territoriale di Lodi—Awarded25 September 2026
FORNITURA DEL PRINCIPIO ATTIVO SUNITINIB CAPSULE 50MGSanitaetsbetrieb der Autonomen Provinz Bozen€53,000Awarded21 September 2026
PROCEDURA NEGOZIATA SENZA PREVIA PUBBLICAZIONE DEL BANDO PER LA FORNITURA DI FARMACI DELLA DITTA GILEAD SCIENCES S.R.L. A FAVORE DELL'AZIENDA SANITARIA DELL'ALTO ADIGESanitaetsbetrieb der Autonomen Provinz Bozen€9,343,200Closed16 September 2026
SERVIZIODI TRASPORTO DIMATERIALE BIOOGICO E FARMACI CHEMIOTERAPICIAzienda Ulss 9 Scaligera—Awarded15 September 2026
FORNITURA DI SACCHE ONCOLOGICHE CONTENENTI SOLUZIONI INFUSIONALI A FAVORE DEL REPARTO FARMACI ANTIBLASTICI DEL COMPRENSORIO SANITARIO DI BOLZANOSanitaetsbetrieb der Autonomen Provinz Bozen—Awarded15 September 2026
FORNITURA DEL FARMACO ELAHERESanitaetsbetrieb der Autonomen Provinz Bozen€139,590Awarded14 September 2026
servizio di convalida periodica del processo asettico (media fill test) con monitoraggio microbiologico contestuale per l'Unità Farmaci Antiblastici del P.O. di SantorsoAzienda Ulss N. 7 Pedemontana—Awarded8 September 2026
FORNITURA DEL FARMACO BREYANZIAzienda Unita Locale Socio-Sanitaria N. 8 Berica€3,151,536Closed7 September 2026
FORNITURA DEL FARMACO YESCARTAAzienda Unita Locale Socio-Sanitaria N. 8 Berica€9,557,085Closed7 September 2026
FORNITURA DEL PRINCIPIO ATTIVO FILGRASTIM SRINGHE 30UI PER CARENZA DEL FARMACO AGGIUDICATOSanitaetsbetrieb der Autonomen Provinz Bozen€65,070Awarded4 September 2026
496_26 XIV AS ESCL CRAV - HERCEPTINAzienda Ulss N. 1 Dolomiti€290,590Awarded2 September 2026
PROT FAR 21873/26 – SDA ALUTARD VESPULA E ALUTARD APEAzienda Socio-Sanitaria Territoriale della Valcamonica€170,294Closed2 September 2026
FORNITURA DEL FARMACO AYVAKYTSanitaetsbetrieb der Autonomen Provinz Bozen€139,510Awarded27 August 2026
PROCEDURA NEGOZIATA PER LA FORNITURA DI FARMACI DELLA DITTA AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. SPA PER LA DURATA DI 48 MESI A FAVORE DELL'AZIENDA SANITARIA DELL'ALTO ADIGESanitaetsbetrieb der Autonomen Provinz Bozen€1,065,600Closed25 August 2026

Competition and prices

In 2025, half of the contracts were worth between €12,000 and €140,000, with a median of €39,000 (679 contracts with a stated awarded value). In 2025 the median value and the share of single-bid contracts stayed as in 2024. The usual procedures: direct award (87%), negotiation without a call for competition (10%), open procedure (1%) — of 1,688 tenders with a stated procedure.

The most contracts went to PFIZER S.R.L. (72), Novartis Farma SPA (56) and Janssen Cilag S.P.A. (48) — together 11% of all contracts.

YearContractsMedian valueMiddle half of valuesBids on averageSingle bid
2024509€39,000€16,000 – €140,000——
2025685€39,000€12,000 – €140,000——
2026 (so far)449€41,000€14,000 – €140,000——
All years1,645€39,000€15,000 – €140,000——

Values: contracts with a stated value in EUR, each value kind on its own (awarded or contract value), approximate (±3 %). Bids: contracts of procedures with competition whose number of bids the source publishes (1–100 bids); the sources publish it for some contracts only (TED ≈ 3 in 4, Spain all, Poland about half, Italy few), so each figure states its base and is shown from 20 contracts. A contract counts in the year of its award (else of its tender). Figures as of 13 November 2026, recomputed every week.

Where you have a chance

In the last 12 months, 0 companies won their first contract in our records here — 0% of the 389 contracts (our records start on 1 January 2024).

Contracts awarded since 1 November 2024 (the last 24 months). Bids as the source publishes them, 1 to 100 per contract, in procedures with competition only (a direct award has one offer by design). As of 13 November 2026.

Main CPV divisions

CPV codes of this topic

  • 33652000 Antineoplastic and immunomodulating agents

A tender belongs here when its main CPV code starts with one of these codes; a tender without a usable CPV code (or with a general one) is matched by words of its title. A tender may belong to up to three topics.

Oncology and immunomodulating drugs in neighbouring countries

No tender in the same niche is open today in neighbouring countries; 154 were published there since 2024.

Public tenders in the EU and the EEA are open to companies from every EU and EEA country on the same terms as local ones, and to companies from countries with a procurement agreement with the EU (such as Switzerland, the United Kingdom and Ukraine) for the contracts it covers. Open means the deadline has not passed (today's date). Neighbours: countries with a land border, a fixed link or a short sea crossing.

Expected soon1

ExpectedBuyerWhatWhy we expect itConfidence
now – Dec 2026
every year
Az. Osp. Univ. Policlinico ModenOncology and immunomodulating drugs
ADESIONE A CONVENZIONE IC PER L'ACQUISTO DEL FARMACO RAPAMUNE (SIROLIMUS) 1 MG - LOTTO 587
Typical value: ≈ €130,000
The buyer has published oncology drug tenders every year in December since 2024.
Earlier tenders: 11/2025, 12/2024
medium

Forecast from public data, not an announcement. Methodology.

Market reports

Oncology and immunomodulating drugs by city

Oncology and immunomodulating drugs in other countries

Oncology and immunomodulating drugs across Europe

Topics in Health, medical equipment and medicines

Questions and answers

Where can I find oncology drug tenders in Italy?
GranTender lists them in one place, from ANAC, ANAC Pubblicità Legale and TED, with their buyers, winners and contract values. Search in one country at a time (the first 5 results) is free; search across all countries at once, full result lists, saved keywords with an e-mail once a week and exports come with a plan.
Who wins the most oncology drug tenders in Italy?
By number of contracts won: PFIZER S.R.L. (72), Novartis Farma SPA (56), Janssen Cilag S.P.A. (48).
Which buyers publish the most oncology drug tenders in Italy?
By number of tenders: Azienda Sanitaria Provinciale (465), Sanitaetsbetrieb der Autonomen Provinz Bozen (221), Azienda Ulss N. 1 Dolomiti (97).
Which CPV codes belong to “Oncology and immunomodulating drugs”?
33652000 Antineoplastic and immunomodulating agents; plus tenders without a usable CPV code whose title names the topic.
How much are contracts for oncology drug tenders in Italy worth?
In 2025, half of the contracts were worth between €12,000 and €140,000, with a median of €39,000 (679 contracts with a stated awarded value). In 2025 the median value and the share of single-bid contracts stayed as in 2024.
Which procedures are used for oncology drug tenders in Italy?
The usual procedures: direct award (87%), negotiation without a call for competition (10%), open procedure (1%) — of 1,688 tenders with a stated procedure.

CPV 2008 (Regulation (EC) No 213/2008), © European Union, Publications Office — via the eForms SDK, CC BY 4.0.